{"id":3869,"date":[80],"date_gmt":"2024-03-26T17:37:01","guid":{"rendered":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/?post_type=resource&p=3869"},"modified":"2024-05-14T08:51:35","modified_gmt":"2024-05-14T08:51:35","slug":"vosoritide%e2%96%bc-therapy-in-children-with-achondroplasia-early-experience-and-practical-considerations-for-clinical-practice","status":"publish","type":"resource","link":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/expert\/resource\/vosoritide%e2%96%bc-therapy-in-children-with-achondroplasia-early-experience-and-practical-considerations-for-clinical-practice\/","title":{"rendered":"Early Experience and Practical Considerations for Clinical Practice"},"content":{"rendered":"","protected":false},"author":2,"template":"","format":[30],"topic":[],"key_opinion_leader":[],"audience":[],"disease_state":[],"region":[],"product":[],"acf":[],"yoast_head":"\n